A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)

Recruiting

Phase 3

A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)

Sponsor:

Longboard Pharmaceuticals

Code:

NCT06660394

Conditions

Dravet Syndrome

Eligibility Criteria

Sex: All

Age: 2 - 65

Healthy Volunteers: Not accepted

Interventions

LP352

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information